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Abstract
Background: Pregnancies in hemodialysis patients are uncommon and difficult to study. Although the chance of a
successful pregnancy and parturition in hemodialysis women has increased over the years, it still remains extremely
low with a high maternal and fetal mortality and morbidity rate.
Case presentation: We reported a case of successful pregnancy and parturition in a 22-year-old Chinese female in
uremic stage of chronic renal failure and undergoing maintenance hemodialysis (three sessions a week) for 6 years.
At the 22nd gestational week, she was diagnosed as pregnant by ultrasound, and started an enhanced hemodialysis
routine (Five sessions a week). At the 32nd gestational week, she got hospitalized and received hemodialysis more
frequently (seven sessions a week). Based on the initial diagnoses, including uremic stage of chronic renal failure,
stage-3 hypertension, single pregnancy of 32nd gestational week, single umbilical artery and polyhydramnios, a
drug therapy consisting of compound amino acid, fructosediphosphate sodium, 10 % L-carnitine, erythropoietin,
polyferose, amlodipine, isosorbidedinitrate, low-molecular weight-heparin, multivitamins and folic acid was given,
and daily examination of the mother and fetus was performed. Under the joint efforts of various departments,
the patient underwent caesarean section at the 34th gestational week due to progressive uterine contraction and
gave birth to a female, well-being baby weighing 1470 g. It has been more than 3 years since the parturition. The
mother has returned to the previous hemodialysis routine, and the child has been growing up healthily.
Conclusion: Although pregnancy in hemodialysis patients is rare, with a high rate of risks. Patients could still gain
a good outcome, if we intensify hemodialysis and enhance the collaboration between the patient, nephrologists,
obstetricians, neonatologist, nutritionists, and other departments.
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Background
Pregnancies in hemodialysis (HD) patients are rare [1],
although the incidence of these pregnancies has increased
since 1971 Confortini reported the first successful case [2].
And compared to normal population, there is a very high
maternal and fetal mortality and morbidity rate in pregnant
women undergoing HD [3, 4]. In order to achieve a success-
ful birth, this situation requires the joint efforts of the patient,
nephrologists, obstetricians, neonatologists, nutritionists and
other departments [3]. Here we reported a case of successful
pregnancy and parturition in a HD patient who was in




The patient was a Chinese woman, 22 years old, married
and nulliparous. The time scale of the patient care was
shown in (Fig. 1).
Past medical history
At the age of 11 (Year 2001), the patient was diagnosed with
chronic glomerulonephritis and stage-3 hypertension
* Correspondence: xuefengjiang@126.com
5Department of Obstetrics and Gynecology, the First Affiliated Hospital of
Ji-nan University, Guangzhou, China
Full list of author information is available at the end of the article
© 2015 Yu et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any
medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Yu et al. BMC Pregnancy and Childbirth  (2015) 15:218 
DOI 10.1186/s12884-015-0642-9
without a definite etiology. She irregularly took Chinese
herbs (details were unknown) hoping to alleviate the pro-
gression of the diseases. Probably due to the treatment
“nonfeasance”, at her age of 16, she stepped into the uremic
stage of CRF. And in order to ease the disease progression,
she started to take 5 mg of amlodipine each day and initi-
ated a routine HD three sessions a week. Since November
2011, the patient started to noticea progressive distending
pain of the abdomen, and was found pregnant for 22 gesta-
tional weeks (GWs) with polyhydramnios (Amniotic Fluid
Index-AFI, was unknown) by ultrasound. From that on, her
HD routine was enhanced into five sessions a week.
Admission condition
On 19th January 2012, the patient came to our hospital.
A comprehensive examination was performed. Her blood
Fig. 1 Time scale of the patient care
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pressure was 152/86 mmHg, body weight 56.6 kg,
height 146.7 cm, and a calculated body mass index was
26.3 kg/m2. Her blood tests were: Blood Urea Nitrogen
(BUN)13.02 mmol/L, Serum Creatinine (Cr) 422 μg/L,
Hemoglobin (Hb) 94 g/L, Hematocrit (Hct) 27 %, Serum
Ferritin (SF) 10.8 μg/L, Red Blood Cell (RBC) 3.35 × 1012/L,
Platelet (PLT) 186 × 109/L, D-Dimer (DD) 0.43 mg/L FEU,
Total Protein (TP) 58.8 g/L, Albumin (ALB) 32.6 g/L,
Serum Potassium (K) 3.7 mmol/L, Serum Sodium (Na)
137 mmol/L, Serum Chlorine (Cl) 103 mmol/L, Serum
Calcium (Ca) 2.08 mmol/L, Creatine Kinase (CK) 95 U/L,
Creatine Kinase-MB isoenzyme (CK-MB) 0.6 μg/L, Cardiac
Troponin I (cTnI) 0.004 μg/L, and N-Terminal pro-Brain
Natriuretic Peptide (NT-proBNP) 124 pg/ml. Abdominal
ultrasound revealed: single pregnancy of 32 GWs, single
umbilical artery, polyhydramnios (AFI 19.5) and fetal growth
restriction (the fetus was as large as that of 29GWs).
Initial treatment protocol
According to the examination results and past medical his-
tory, the patient was initially diagnosed with: CRF (uremic
stage), stage-3 hypertension, single pregnancy of 32GWs,
single umbilical artery, polyhydramnios, fetal growth restric-
tion, and slight anemia. In order to afford a comprehensive
treatment, nephrologists, obstetricians, neonatologists, nutri-
tionists and cardiovascular department together established
the following therapeutic regimen:
Daily HD of 240 min was performed on the patient,
followed by intravenous supplement of 250 ml of com-
pound amino acid, 20 ml of 10 % L-carnitine, and 10 g of
fructose diphosphate sodium. 5 mg of amlodipine and
0.296 g of isosorbidedinitrate were given per day to control
the blood pressure. 0.4 mg of folic acid and 150 mg of poly-
ferose each day and 300 IU of erythropoietin (EPO) twice a
week were applied to alleviate anemia. Additionally, close
observation of maternal and fetal conditions was required:
auscultation of fetal heart rate (FHR), calculation of fetal
movement, maternal electrocardiogram (ECG), check of
maternal vital signs, measurement of maternal abdominal
circumference, and maternal blood tests were strictly per-
formed each day. Color Doppler ultrasound was performed
once a week. Non-Stress-Test (NST) was performed 3
times a week. Additionally, blood examination of myocar-
dial enzymes was executed in case of heart failure.
Disease progression
From 4th February 2012, the patient started feeling ab-
dominal intending pain with paroxysmal severe abdominal
cramps. Abdominal ultrasound was performed, indicating:
single pregnancy of 34+1 GWs, single umbilical artery,
fetal growth restriction, and polyhydramnios (AFI 22.9).
The blood tests were: BUN 14.19 mmol/L, Cr368 μg/L,
Hb 90 g/L, Hct 24 %, SF 11.3 μg/L, RBC 3.26 × 1012/L,
PLT 194 × 109/L, DD 0.24 mg/L FEU, TP 56.8 g/L, ALB
32.3 g/L, K 3.5 mmol/L, Na 139 mmol/L, Cl 108 mmol/L,
Ca 2.20 mmol/L, CK 75 U/L, CK-MB 0.3 μg/L, cTnI
0.000 μg/L, NT-proBNP 119 pg/ml. NST confirmed that
the paroxysmal abdominal pain was due to uterine contrac-
tion, indicating a great risk of premature birth. To facilitate
the maturation of fetal lungs, 6 mg of dexamethasone twice
a day was given to the patient intramuscularly for 2 days.
On 7th February 2012 (at the 34+4thGW), no fetal
movement was observed, and a non-reaction type of
NST was presented. The baseline of FHR was 145 beats
per minute, without obvious FHR fluctuation even during
HD. Intrauterine fetal distress was highly suspected, and so
we decided to cease the pregnancy immediately. On that
day, the patient underwent caesarean section and was deliv-
ered of a female, well-being baby weighing 1470 g. The
Apgar score was 5, 8 and 9 at the 1st, 5th and 10th minutes
respectively. The placenta was pathologically examined
(Fig. 2), and the result revealed placental dysfunction, single
umbilical artery and vascular pathological change caused by
hypertension.
On 8th February 2012, the patient felt chest tight-
ness and coughed up foamy sputum. In case of heart
failure, ECG was performed and blood tests were ex-
amined: BUN 13.15 mmol/L, Cr376 μg/L, K 6.6 mmol/
L, Na 134 mmol/L, Cl 110 mmol/L, Ca 2.14 mmol/L,
CK 158 U/L, CK-MB 3.3 μg/L, cTnI 0.051 μg/L, NT-
proBNP 122 pg/ml. Although the ECG and myocardial
enzymes did not indicate any abnormity, the transient
hyperkalemia could be malicious and fatal to postpartum
women with CRF. Therefore HD was imminently per-
formed to alleviate the hyperkalemia. And fortunately, the
situation was controlled in time.
Outcomes and 3-year follow-up
During the following days, the mother was in a stable
condition, and there was no evidence of neonatal
pathology. Therefore, they were discharged from the
hospital on the 8th post-delivery day. The patient still
suffered from anuria, and regularly revisited our hospital
for HD three times a week.
Recently the mother and child returned to our hospital.
The mother’s condition had been stabilized by regular
hemolysis, and the child had been growing up healthily.
Literature review and discussion
Uremia-associated hypothalamo-pituitary dysfunction and
malnutrition usually result in amenorrhea and anovulation,
and thus disturbances in menstruation and fertility are
commonly encountered in women with CRF, leading to a
low pregnancy rate in these patients [1, 5]. HD is per-
formed on CRF patients, especially those suffered from
anuria, to alleviate the uremic condition. However, dis-
turbance of body homeostasis is a common complication
of HD [1, 4, 5]. Long-term nausea and vomiting caused by
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acid-base and electrolytes imbalance may cover the early
pregnancy reactions in HD patients, delay the treatment,
and lower the successful rate of HD parturition. Since
1971 Confortini et al. [2] reported the first successful case
of HD pregnancy, further cases followed. In 1980 the
European Dialysis and Transplant Association (EDTA)
reported a pregnancy incidence of 0.9 % [6], while recent
publications reported pregnancy in 1.0–7.0 % women on
chronic dialysis, and 30–50 % of those pregnancies
resulted in delivery of a surviving infant [7]. Although the
successful incidence tends to increase, it is still uncom-
mon, and with high maternal and fetal mortality and mor-
bidity rate [3, 4].
In women of childbearing age on dialysis, menstrual
irregularity, amenorrhea, sexual dysfunction, nausea and
elevated beta-subunit of human chorionic gonadotropin
(β-HCG) have been observed in some patients with renal
failure which may give a false-positive pregnant test [8, 9].
Early diagnosis is advantageous for maternal fitness
and fetal viability, since it allows intensified dialysis
early in pregnancy and an early review of medications
contraindicated during pregnancy. In our case, the
patient became pregnant after 6 years of HD, and she
was not found pregnant until the 22nd GW. The late
diagnosis might have delayed the intensive antenatal
care and reduced the successful chance. However, the
adequate HD might largely contribute to the success-
ful maintenance of pregnancy and parturition in our
case [1, 4, 5].
Polyhydramnios is a common complication in pregnant
women undergoing HD with an incidence ranging from
30–70 % [8–10]. It has been reported that intensified HD
could alleviate polyhydramnios by reducing fluid over-
burden and lowering osmotic pressure [7, 11]. In our case,
the patient received 5 HD sessions a week since the 22nd
GW. Her AFI was 19.5 at the 32nd GW, and started daily
HD. It seemed that the intensified HD didn’t reduce the
amniotic fluidto a better level, as AFI increased to 22.9 at
the 34th+1 GW, yet the pregnant outcome and fetal viability
was impressive. This result is corresponding to the previous
finding that polyhydramnios was associated with a favorable
fetal outcome in pregnant women undergoing long-term
HD [12, 13].
The pathophysiology of polyhydramnios has not yet
been clarified. An influence of the fetal osmotic diuresis,
caused by the increased concentration of urea and related
substances in maternal blood, has been proposed [12].
Although intensified HD may ameliorate the exacerbation
of polyhydramnios, the influence of osmotic diuresis may
overwhelm. This may explain why the AFI failed to de-
crease despite of daily HD. Additionally, fetuses with uter-
oplacental insufficiency habitually shunt blood away from
Fig. 2 Placenta and its pathological examination. a Placenta by naked eyes. The volume is 18 × 13 × (1.5–2) cm, with sections of dull-red
color and complete placental membrane, no cyst can be found. b Chorionic villi of placenta under microscope (HE × 200). Mild edema and
increased syncytial cell nodules can be seen in partial villi, indicating placental dysfunction. c A chorionic blood vessel under microscope
(HE × 400). Chorionic blood vessel presents hyaline degeneration and fibrous necrosis, according with the diagnosis of hypertension. d Umbilical artery
under microscope (HE × 400). There is only one artery in umbilical cord, with a thickened wall and a narrow lumen, according with the diagnosis of single
umbilical artery
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nonessential organs, such as kidneys, to decrease urine
output and thus amniotic fluid volume, leading to oligohy-
dramnios [4]. The presence of polyhrydramnios may be
an indirect evidence of adequate placental function and
therefore be associated with better fetal prognosis. Further
studies are in need to discuss the relationship between the
presence of polyhydramnios and the “doses” of HD.
Hypertension is the most frequently reported maternal
complication in this population [14]. Due to combination
of hypertention and inefficient renal function, the incidence
of pre-eclampsia is alarmingly high, occurring in 50 % of
pregnant women with pre-existing renal diseases [15, 16].
The presence of pre-eclampsia had a negative impact on
the successful delivery rate and accounted for 57 % of
perinatal deaths, and interventions lowering the incidence
or severity of pre-eclampsia may potentially improve fetal
outcome [4]. However, the fluctuant blood pressure, pro-
teinuria as well as BUN and Cr level make the diagnosis
of pre-eclampsia in patients undergoing HD exceedingly
difficult, delaying the early medical intervention and in-
creasing the maternal and fetal morbidity and mortality.
In this case, the patient had taken amlodipine to control
blood pressure for 6 years. When being found pregnant,
she continued amlodipine therapy and started intensified
HD. In case of pre-eclampsia, blood pressure, blood rou-
tine test, coagulation, and heart function was frequently
measured, and Color Doppler ultrasound involving the
uterine arteries was performed at least once a week. This
patient’s renal dysfunction and hypertion-before-pregnancy
awfully increased the risk of pre-eclampsia. Yet fortunately
there were neither clinical manifestations of pre-eclampsia
such as severe headache, blurred vision, and palpitation,
nor obvious abnormality of the aforementioned tests. The
combination of antihypertensive medication and en-
hanced HD might facilitate the balance of body fluid
and stabilization of blood pressure, contributing to the
successful outcome.
Low dose of aspirin had been applied to prevent
pregnancy-induced hypertension safely [17, 18]. How-
ever, animal studies have shown the increased risk of
congenital anomalies caused by aspirin, and data from
human studies remains conflicting [19]. Moreover, the
possible preventive effect of aspirin aims at the early
pregnancy. The patient came to our hospital at the 32nd
GW, and with a considerable risk of premature delivery.
Therefore, aspirin was not applied to this patient.
Anemia occurs during pregnancy presumably due to the
hemodilution caused by greater vascular volume, EPO re-
sistance as a result of increased cytokine production during
pregnancy, and high demand of red blood cell production
for fetal growth [14]. Pregnant women undergoing HD are
more likely to have anemia, because of the exceeding loss
of iron and red blood cells from frequent HD. Previous
studies have shown an increased rate of preterm delivery in
women with anemia [20, 21]. The widely accepted indica-
tors of anemia, hemoglobin level and hematocrit, have
also been found positively related to the successful rate of
parturition and fetal birth weight [22]. Therefore, EPO are
regularly given to pregnant dialysis patients, with doses
requiring an increase of about 50 %. Also, frequent moni-
toring of hemoglobin level and hematocrit is required,
with a target value of 100–110 g/L and >30 % respectively
[4, 23]. In our case, 0.4 mg folic acid and 150 mg of poly-
feroseeach day and 300 IU of erythropoietin twice a week
were given to the patient. Her hemoglobin level and
hematocrit were kept stable and near the target value.
Maternal dry weight and weight gain should be regularly
evaluated and adjustedaccording to the estimated weight
of the placenta and fetus as well as the increase in plasma
volume. In the first trimester, the mother should gain a
minimum of 1–1.5 kg per week. After this, weight
should increase by 0.45–1 kg per week [14]. There is
little information on the nutritional status of pregnant
dialysis patients, but 1 g/kg/day protein intake for the
mother plus 20 g/day for fetal development has been
suggested [6, 14, 23].
In maintenance HD, carnitine is lost through dialytic
membranes, leading in selected patients to carnitine deple-
tion with a relative increase of the esterified forms [24].
The concentration of plasma amino acids and glucose also
falls after HD, resulting a state of fasting and wasting [25].
Thus the intravenous supplement of compound amino
acid, L-carnitine, and fructose diphosphate sodium were
given to improve the nutritional status of the patient after
each HD session.
Fetal anomalies, including spina bifida, encephalocele,
cystic hygroma, valvular incompetence, and kyphoscoliosis,
belong to the worst situations of pregnancy. The risk fac-
tors and/or indications of fetal anomalies include poly- and
oligohydramnios, single umbilical artery, maternal diseases
such as diabetes, hypertension and infections [26]. In our
case, the patient was diagnosed with polyhydramnios, single
umbilical artery, anemia, hypertension, and uremic stage of
CRF. Therefore the incidence of fetal anomaly is exceed-
ingly high. We carried on color Doppler ultrasound for the
patient once a week tomonitor the fetal condition, and for-
tunately this was a well-being fetus.
Maternal mortality is relatively low and less reported
[1, 4]. Cesarean section delivery is common among
women on dialysis and is most often prompted by pre-
mature rupture of membranes. Infants born to women
on HD are usually premature, with multiple causes, such
as polyhydramnios, maternal hypertension, premature
rupture of the membranes and et al. In our case, the
patient underwent progressive uterine contraction at the
34th GW, and intrauterine fetal distress was indicated by
NST. Thus we ceased the pregnancy by caesarean section
and delivered a female, well-being baby of which the
Yu et al. BMC Pregnancy and Childbirth  (2015) 15:218 Page 5 of 6
weight was 1470 g. The patient recovered satisfactorily
and returned to HD regimen of 3 sessions a week with
good tolerance. Currently, the baby hasn’t yet had any ob-
vious pathological change.
Conclusions
The pregnancy of women on chronic dialysis is at very
high risk but it should reach a good outcome with multi-
disciplinary management, by nephrologists, obstetricians,
neonatologists, nutritionists and other departments. We
advise that all aspects of HD, including duration, ad-
equacy, nutrition, anemia, and blood pressure control
should be closely followed throughout the course of preg-
nancy. Finally, since pregnancy can occur in women on
dialysis, health care providers should discuss fertility and
contraception with their premenopausal dialysis patients.
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Written informed consent was obtained from the patient
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